Test to Stay in School: COVID-19 Testing Following Exposure in School Communities
Primary Purpose
Covid19
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
COVID-19 Testing
Sponsored by

About this trial
This is an interventional other trial for Covid19
Eligibility Criteria
Inclusion Criteria:
- Consent completed
- Child or adult that is part of a school community
- Known exposure to SARS-CoV-2 in the school setting (e.g. school bus, classroom, school sporting event, etc.)
Exclusion Criteria:
- None
Sites / Locations
- Participating NC School Districts
Arms of the Study
Arm 1
Arm Type
Other
Arm Label
COVID-19 Exposure Testing
Arm Description
Outcomes
Primary Outcome Measures
Number of students with positive COVID-19 test following known within-school exposure, reported as a proportion (%) of the total number of participants enrolled in the study, and measured by a COVID-19 test.
Number of staff with positive COVID-19 tests following known within-school exposure, reported as a proportion (%) of the total number of participants enrolled in the study, and measured by a COVID-19 test.
Number of exposures (as measured by nurse report) undergoing the test-to-stay protocol that result in additional transmission, reported as a proportion (%) of the total number of participants enrolled in the study.
Time (in days) to test positivity (reported as a mean) among those exposed to SARS-CoV-2 and undergoing the test-to-stay protocol.
Secondary Outcome Measures
Number of masked students with positive test who were exposed from masked versus unmasked individuals, reported as a proportion (%) of the total number of participants enrolled in the study, and measured by a positive COVID-19 test.
Number of masked staff with positive test who were exposed from masked compared to unmasked individuals, reported as a proportion (%) of the total number of participants enrolled in the study, and measured by a positive COVID-19 test.
Number of unmasked students with positive tests who were exposed from masked compared to unmasked individuals, reported as a proportion (%) of the total number of participants enrolled in the study, and measured by a positive COVID-19 test.
Number of unmasked staff with positive tests who were exposed from masked compared to unmasked individuals, reported as a proportion (%) of the total number of participants enrolled in the study, and measured by a positive COVID-19 test.
Number of students with positive COVID-19 test after indoor vs. outdoor exposure, reported as a proportion (%) of the total number of participants enrolled in the study, and measured by a positive COVID-19 test.
Number of students with positive COVID-19 test after athletic vs. classroom exposure, reported as a proportion (%) of the total number of participants enrolled in the study, and measured by a positive COVID-19 test.
Number of students with positive COVID-19 test after bus vs. classroom exposure, reported as a proportion (%) of the total number of participants enrolled in the study, and measured by a positive COVID-19 test.
Total number of school days missed due to symptoms after exposure, reported as a mean.
Total number of school days missed due to isolation after positive COVID-19 test, reported as a mean.
Total number of school days missed due to quarantine after SARS-CoV-2 exposure, reported as a mean.
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT05052580
Brief Title
Test to Stay in School: COVID-19 Testing Following Exposure in School Communities
Official Title
Test to Stay in School: COVID-19 Testing Following Exposure in School Communities
Study Type
Interventional
2. Study Status
Record Verification Date
May 2022
Overall Recruitment Status
Completed
Study Start Date
October 1, 2021 (Actual)
Primary Completion Date
March 28, 2022 (Actual)
Study Completion Date
March 28, 2022 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Duke University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Participants in school communities who have been exposed to SARS-CoV-2 will be tested for COVID-19 on the day of exposure (day 1) and at days 3, 5, and 7 following initial known exposure. Mitigation practices including masking, the context of exposure (classroom, school bus, after school sporting event, lunch, etc.), and results of COVID-19 test will be documented.
Detailed Description
This is a prospective, interventional study with a primary objective of evaluating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission following exposure in Kindergarten through 12th grade schools. Participants will be tested with a COVID-19 testing kit that is Food and Drug Administration (FDA)-authorized under an emergency use authorization (EUA) for non-prescription use for both symptomatic and asymptomatic evaluation in children and adults. Participants who consent to participate in this study will be tested at days 1, 3, 5, and 7 following a known COVID-19 exposure on day 0. If a participant does not know of the exposure until more than one day following they exposure, they will be tested on the day they become aware of the exposure and then resume the aforementioned testing schedule (e.g. participant identifies exposure 3 days after the exposure, test on day 3, day 5, and day 7).
If the COVID-19 tests are negative, the participant will remain in the school environment. A positive COVID-19 test or the development of symptoms on any day after exposure would require isolation according to school, local and state guidelines. Demographic information, daily presence or absence of symptoms, whether the infected person or close contact was masked, setting of the exposure, test results, and school absences will be collected following consent. Data regarding school level mitigation practices will also be collected. Data collected from this study may be combined with school-provided data and publically available community data.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Covid19
7. Study Design
Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
4727 (Actual)
8. Arms, Groups, and Interventions
Arm Title
COVID-19 Exposure Testing
Arm Type
Other
Intervention Type
Other
Intervention Name(s)
COVID-19 Testing
Intervention Description
Participants who consent to participate in this study will be tested at days 1, 3, 5, and 7 following a known COVID-19 exposure on day 0. If the COVID-19 tests are negative, the participant will remain in the school environment. A positive COVID-19 test or the development of symptoms on any day after exposure would require isolation according to school, local and state guidelines.
Primary Outcome Measure Information:
Title
Number of students with positive COVID-19 test following known within-school exposure, reported as a proportion (%) of the total number of participants enrolled in the study, and measured by a COVID-19 test.
Time Frame
2 years
Title
Number of staff with positive COVID-19 tests following known within-school exposure, reported as a proportion (%) of the total number of participants enrolled in the study, and measured by a COVID-19 test.
Time Frame
2 years
Title
Number of exposures (as measured by nurse report) undergoing the test-to-stay protocol that result in additional transmission, reported as a proportion (%) of the total number of participants enrolled in the study.
Time Frame
2 years
Title
Time (in days) to test positivity (reported as a mean) among those exposed to SARS-CoV-2 and undergoing the test-to-stay protocol.
Time Frame
2 years
Secondary Outcome Measure Information:
Title
Number of masked students with positive test who were exposed from masked versus unmasked individuals, reported as a proportion (%) of the total number of participants enrolled in the study, and measured by a positive COVID-19 test.
Time Frame
2 years
Title
Number of masked staff with positive test who were exposed from masked compared to unmasked individuals, reported as a proportion (%) of the total number of participants enrolled in the study, and measured by a positive COVID-19 test.
Time Frame
2 years
Title
Number of unmasked students with positive tests who were exposed from masked compared to unmasked individuals, reported as a proportion (%) of the total number of participants enrolled in the study, and measured by a positive COVID-19 test.
Time Frame
2 years
Title
Number of unmasked staff with positive tests who were exposed from masked compared to unmasked individuals, reported as a proportion (%) of the total number of participants enrolled in the study, and measured by a positive COVID-19 test.
Time Frame
2 years
Title
Number of students with positive COVID-19 test after indoor vs. outdoor exposure, reported as a proportion (%) of the total number of participants enrolled in the study, and measured by a positive COVID-19 test.
Time Frame
2 years
Title
Number of students with positive COVID-19 test after athletic vs. classroom exposure, reported as a proportion (%) of the total number of participants enrolled in the study, and measured by a positive COVID-19 test.
Time Frame
2 years
Title
Number of students with positive COVID-19 test after bus vs. classroom exposure, reported as a proportion (%) of the total number of participants enrolled in the study, and measured by a positive COVID-19 test.
Time Frame
2 years
Title
Total number of school days missed due to symptoms after exposure, reported as a mean.
Time Frame
2 years
Title
Total number of school days missed due to isolation after positive COVID-19 test, reported as a mean.
Time Frame
2 years
Title
Total number of school days missed due to quarantine after SARS-CoV-2 exposure, reported as a mean.
Time Frame
2 years
10. Eligibility
Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Consent completed
Child or adult that is part of a school community
Known exposure to SARS-CoV-2 in the school setting (e.g. school bus, classroom, school sporting event, etc.)
Exclusion Criteria:
None
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Kanecia Zimmerman, MD, MPH
Organizational Affiliation
Duke University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Participating NC School Districts
City
Durham
State/Province
North Carolina
ZIP/Postal Code
27707
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
35437593
Citation
Campbell MM, Benjamin DK, Mann T, Fist A, Kim H, Edwards L, Rak Z, Brookhart MA, Anstrom K, Moore Z, Tilson EC, Kalu IC, Boutzoukas AE, Moorthy GS, Uthappa D, Scott Z, Weber DJ, Shane AL, Bryant KA, Zimmerman KO; ABC SCIENCE COLLABORATIVE. Test-to-Stay After Exposure to SARS-CoV-2 in K-12 Schools. Pediatrics. 2022 May 1;149(5):e2021056045. doi: 10.1542/peds.2021-056045.
Results Reference
derived
Learn more about this trial
Test to Stay in School: COVID-19 Testing Following Exposure in School Communities
We'll reach out to this number within 24 hrs